This article is from the source 'nytimes' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.nytimes.com/2020/05/05/us/politics/rick-bright-coronavirus-whistleblower.html
The article has changed 28 times. There is an RSS feed of changes available.
Previous version
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
Next version
Version 11 | Version 12 |
---|---|
Virus Whistle-Blower Says Trump Administration Steered Contracts to Cronies | Virus Whistle-Blower Says Trump Administration Steered Contracts to Cronies |
(32 minutes later) | |
WASHINGTON — A federal scientist who says he was ousted from his job amid a dispute over an unproven coronavirus treatment pushed by President Trump said Tuesday that top administration officials repeatedly pressured him to steer millions of dollars in contracts to the clients of a well-connected consultant. | WASHINGTON — A federal scientist who says he was ousted from his job amid a dispute over an unproven coronavirus treatment pushed by President Trump said Tuesday that top administration officials repeatedly pressured him to steer millions of dollars in contracts to the clients of a well-connected consultant. |
Rick Bright, who was director of the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority until his removal in April, said in a formal whistle-blower complaint that he had been protesting “cronyism” and contract abuse since 2017. | Rick Bright, who was director of the Department of Health and Human Services’ Biomedical Advanced Research and Development Authority until his removal in April, said in a formal whistle-blower complaint that he had been protesting “cronyism” and contract abuse since 2017. |
Questionable contracts have gone to “companies with political connections to the administration,” the complaint said, including a drug company tied to a friend of Jared Kushner’s, President Trump’s son-in-law and senior adviser. It said Dr. Bright was retaliated against by his superiors, who pushed him out because of “his efforts to prioritize science and safety over political expediency.” | Questionable contracts have gone to “companies with political connections to the administration,” the complaint said, including a drug company tied to a friend of Jared Kushner’s, President Trump’s son-in-law and senior adviser. It said Dr. Bright was retaliated against by his superiors, who pushed him out because of “his efforts to prioritize science and safety over political expediency.” |
The 89-page complaint, filed with the Office of Special Counsel, which protects federal whistle-blowers, also said Dr. Bright “encountered opposition” from department superiors — including Health and Human Services Secretary Alex M. Azar II — when he pushed as early as January for the necessary resources to develop drugs and vaccines to counter the emerging coronavirus pandemic. | The 89-page complaint, filed with the Office of Special Counsel, which protects federal whistle-blowers, also said Dr. Bright “encountered opposition” from department superiors — including Health and Human Services Secretary Alex M. Azar II — when he pushed as early as January for the necessary resources to develop drugs and vaccines to counter the emerging coronavirus pandemic. |
The report provides a window into the inner workings of BARDA, a tiny agency created in 2006 as a response to the Sept. 11, 2001, attacks. It partners with industry in developing “medical countermeasures” that can be stockpiled by the federal government to combat biological or chemical attacks and pandemic threats. | The report provides a window into the inner workings of BARDA, a tiny agency created in 2006 as a response to the Sept. 11, 2001, attacks. It partners with industry in developing “medical countermeasures” that can be stockpiled by the federal government to combat biological or chemical attacks and pandemic threats. |
BARDA has spent billions of dollars on contracts with dozens of different suppliers, including major pharmaceutical companies and smaller biotechnology firms. | BARDA has spent billions of dollars on contracts with dozens of different suppliers, including major pharmaceutical companies and smaller biotechnology firms. |
Both allies and Dr. Bright say his nearly four-year tenure as the head of BARDA was marked by clashes with his superiors — especially Dr. Robert Kadlec, the assistant secretary of health for preparedness and response — and tension with some industry executives. Dr. Bright conceded in the complaint that those clashes came to a head after he leaked information on the dispute over the malaria drug hydroxychloroquine to a reporter from Reuters. | Both allies and Dr. Bright say his nearly four-year tenure as the head of BARDA was marked by clashes with his superiors — especially Dr. Robert Kadlec, the assistant secretary of health for preparedness and response — and tension with some industry executives. Dr. Bright conceded in the complaint that those clashes came to a head after he leaked information on the dispute over the malaria drug hydroxychloroquine to a reporter from Reuters. |
A lawyer for Dr. Bright, Debra Katz, said he felt a “moral obligation” to get the word out that the administration was pressing to stockpile an unproven and potentially dangerous coronavirus treatment, which was supplied by drugmakers in India and Pakistan and had not been certified by the Food and Drug Administration. | A lawyer for Dr. Bright, Debra Katz, said he felt a “moral obligation” to get the word out that the administration was pressing to stockpile an unproven and potentially dangerous coronavirus treatment, which was supplied by drugmakers in India and Pakistan and had not been certified by the Food and Drug Administration. |
The complaint says top Department of Health and Human Services officials, including Dr. Kadlec, who oversees the strategic national stockpile, overruled scientific experts while awarding contracts to firms represented by the consultant, John Clerici. Mr. Clerici, a founder of a Washington-based firm, Tiber Creek Partners, was instrumental, along with Dr. Kadlec, in writing the legislation that created BARDA. | The complaint says top Department of Health and Human Services officials, including Dr. Kadlec, who oversees the strategic national stockpile, overruled scientific experts while awarding contracts to firms represented by the consultant, John Clerici. Mr. Clerici, a founder of a Washington-based firm, Tiber Creek Partners, was instrumental, along with Dr. Kadlec, in writing the legislation that created BARDA. |
“Dr. Bright was vocal about his concerns regarding the inappropriate and possibly illegal communications between Mr. Clerici, Dr. Kadlec, Mr. Shuy and Mr. Meekins,” the complaint stated, referring to Bryan Shuy and Chris Meekins, two other department officials. | “Dr. Bright was vocal about his concerns regarding the inappropriate and possibly illegal communications between Mr. Clerici, Dr. Kadlec, Mr. Shuy and Mr. Meekins,” the complaint stated, referring to Bryan Shuy and Chris Meekins, two other department officials. |
A spokeswoman for the department, Caitlin Oakley, did not address the complaints about officials there. | A spokeswoman for the department, Caitlin Oakley, did not address the complaints about officials there. |
“Dr. Bright was transferred to N.I.H. to work on diagnostics testing — critical to combating Covid-19 — where he has been entrusted to spend upward of $1 billion to advance that effort,” she said in an emailed statement. “We are deeply disappointed that he has not shown up to work on behalf of the American people and lead on this critical endeavor.” | “Dr. Bright was transferred to N.I.H. to work on diagnostics testing — critical to combating Covid-19 — where he has been entrusted to spend upward of $1 billion to advance that effort,” she said in an emailed statement. “We are deeply disappointed that he has not shown up to work on behalf of the American people and lead on this critical endeavor.” |
Dr. Bright was initially offered a narrower role at the National Institutes of Health to work on a new “Shark Tank”-style program to develop coronavirus treatments, but Ms. Katz told reporters he “has no role” and did not receive his last paycheck. A spokeswoman, Kendra Barkoff Lamy, later said that, at his doctor’s direction, Dr. Bright “has been on sick leave due to hypertension caused by this current situation.” | Dr. Bright was initially offered a narrower role at the National Institutes of Health to work on a new “Shark Tank”-style program to develop coronavirus treatments, but Ms. Katz told reporters he “has no role” and did not receive his last paycheck. A spokeswoman, Kendra Barkoff Lamy, later said that, at his doctor’s direction, Dr. Bright “has been on sick leave due to hypertension caused by this current situation.” |
In a statement, Mr. Clerici said he “unequivocally” denied any wrongdoing, adding: “It’s sad that during a pandemic, Dr. Bright and his team have chosen to distract people like Dr. Kadlec, who are critical to the response, with politically motivated allegations. The record is clear that his allegations are false and will be proven so.” | In a statement, Mr. Clerici said he “unequivocally” denied any wrongdoing, adding: “It’s sad that during a pandemic, Dr. Bright and his team have chosen to distract people like Dr. Kadlec, who are critical to the response, with politically motivated allegations. The record is clear that his allegations are false and will be proven so.” |
The complaint, written by Ms. Katz and her law partner, Lisa Banks, identifies four specific instances in which Dr. Bright felt Mr. Clerici exerted undue influence. At one point, it said, Dr. Bright called for an investigation by the inspector general “to help break up the ‘cottage industry’ of marketing consultants and political influence into these contracts.” | The complaint, written by Ms. Katz and her law partner, Lisa Banks, identifies four specific instances in which Dr. Bright felt Mr. Clerici exerted undue influence. At one point, it said, Dr. Bright called for an investigation by the inspector general “to help break up the ‘cottage industry’ of marketing consultants and political influence into these contracts.” |
Dr. Bright also said Mr. Clerici pushed, albeit unsuccessfully, for an extension of a contract awarded to a company run by someone who was “friends with Jared” and “has Hollywood connections.” In a brief interview, Mr. Clerici said the “conversation never happened.” | Dr. Bright also said Mr. Clerici pushed, albeit unsuccessfully, for an extension of a contract awarded to a company run by someone who was “friends with Jared” and “has Hollywood connections.” In a brief interview, Mr. Clerici said the “conversation never happened.” |
The document paints Dr. Bright as sounding the alarm about the emerging coronavirus threat and pressing his superiors to do more to prepare — including purchasing masks that would later turn out to be in short supply — at a time when Mr. Azar was downplaying the crisis. | The document paints Dr. Bright as sounding the alarm about the emerging coronavirus threat and pressing his superiors to do more to prepare — including purchasing masks that would later turn out to be in short supply — at a time when Mr. Azar was downplaying the crisis. |
On Jan. 23, he met with Mr. Azar and Dr. Kadlec to press “for urgent access to funding, personnel and clinical specimens, including viruses,” that would be necessary to develop treatments, the complaint said. But Mr. Azar and Dr. Kadlec “asserted that the United States would be able to contain the virus” through travel bans, the complaint said, adding that Dr. Bright was cut out of future department meetings related to Covid-19. | On Jan. 23, he met with Mr. Azar and Dr. Kadlec to press “for urgent access to funding, personnel and clinical specimens, including viruses,” that would be necessary to develop treatments, the complaint said. But Mr. Azar and Dr. Kadlec “asserted that the United States would be able to contain the virus” through travel bans, the complaint said, adding that Dr. Bright was cut out of future department meetings related to Covid-19. |
Updated June 22, 2020 | Updated June 22, 2020 |
A commentary published this month on the website of the British Journal of Sports Medicine points out that covering your face during exercise “comes with issues of potential breathing restriction and discomfort” and requires “balancing benefits versus possible adverse events.” Masks do alter exercise, says Cedric X. Bryant, the president and chief science officer of the American Council on Exercise, a nonprofit organization that funds exercise research and certifies fitness professionals. “In my personal experience,” he says, “heart rates are higher at the same relative intensity when you wear a mask.” Some people also could experience lightheadedness during familiar workouts while masked, says Len Kravitz, a professor of exercise science at the University of New Mexico. | A commentary published this month on the website of the British Journal of Sports Medicine points out that covering your face during exercise “comes with issues of potential breathing restriction and discomfort” and requires “balancing benefits versus possible adverse events.” Masks do alter exercise, says Cedric X. Bryant, the president and chief science officer of the American Council on Exercise, a nonprofit organization that funds exercise research and certifies fitness professionals. “In my personal experience,” he says, “heart rates are higher at the same relative intensity when you wear a mask.” Some people also could experience lightheadedness during familiar workouts while masked, says Len Kravitz, a professor of exercise science at the University of New Mexico. |
The steroid, dexamethasone, is the first treatment shown to reduce mortality in severely ill patients, according to scientists in Britain. The drug appears to reduce inflammation caused by the immune system, protecting the tissues. In the study, dexamethasone reduced deaths of patients on ventilators by one-third, and deaths of patients on oxygen by one-fifth. | The steroid, dexamethasone, is the first treatment shown to reduce mortality in severely ill patients, according to scientists in Britain. The drug appears to reduce inflammation caused by the immune system, protecting the tissues. In the study, dexamethasone reduced deaths of patients on ventilators by one-third, and deaths of patients on oxygen by one-fifth. |
The coronavirus emergency relief package gives many American workers paid leave if they need to take time off because of the virus. It gives qualified workers two weeks of paid sick leave if they are ill, quarantined or seeking diagnosis or preventive care for coronavirus, or if they are caring for sick family members. It gives 12 weeks of paid leave to people caring for children whose schools are closed or whose child care provider is unavailable because of the coronavirus. It is the first time the United States has had widespread federally mandated paid leave, and includes people who don’t typically get such benefits, like part-time and gig economy workers. But the measure excludes at least half of private-sector workers, including those at the country’s largest employers, and gives small employers significant leeway to deny leave. | The coronavirus emergency relief package gives many American workers paid leave if they need to take time off because of the virus. It gives qualified workers two weeks of paid sick leave if they are ill, quarantined or seeking diagnosis or preventive care for coronavirus, or if they are caring for sick family members. It gives 12 weeks of paid leave to people caring for children whose schools are closed or whose child care provider is unavailable because of the coronavirus. It is the first time the United States has had widespread federally mandated paid leave, and includes people who don’t typically get such benefits, like part-time and gig economy workers. But the measure excludes at least half of private-sector workers, including those at the country’s largest employers, and gives small employers significant leeway to deny leave. |
So far, the evidence seems to show it does. A widely cited paper published in April suggests that people are most infectious about two days before the onset of coronavirus symptoms and estimated that 44 percent of new infections were a result of transmission from people who were not yet showing symptoms. Recently, a top expert at the World Health Organization stated that transmission of the coronavirus by people who did not have symptoms was “very rare,” but she later walked back that statement. | So far, the evidence seems to show it does. A widely cited paper published in April suggests that people are most infectious about two days before the onset of coronavirus symptoms and estimated that 44 percent of new infections were a result of transmission from people who were not yet showing symptoms. Recently, a top expert at the World Health Organization stated that transmission of the coronavirus by people who did not have symptoms was “very rare,” but she later walked back that statement. |
Touching contaminated objects and then infecting ourselves with the germs is not typically how the virus spreads. But it can happen. A number of studies of flu, rhinovirus, coronavirus and other microbes have shown that respiratory illnesses, including the new coronavirus, can spread by touching contaminated surfaces, particularly in places like day care centers, offices and hospitals. But a long chain of events has to happen for the disease to spread that way. The best way to protect yourself from coronavirus — whether it’s surface transmission or close human contact — is still social distancing, washing your hands, not touching your face and wearing masks. | Touching contaminated objects and then infecting ourselves with the germs is not typically how the virus spreads. But it can happen. A number of studies of flu, rhinovirus, coronavirus and other microbes have shown that respiratory illnesses, including the new coronavirus, can spread by touching contaminated surfaces, particularly in places like day care centers, offices and hospitals. But a long chain of events has to happen for the disease to spread that way. The best way to protect yourself from coronavirus — whether it’s surface transmission or close human contact — is still social distancing, washing your hands, not touching your face and wearing masks. |
A study by European scientists is the first to document a strong statistical link between genetic variations and Covid-19, the illness caused by the coronavirus. Having Type A blood was linked to a 50 percent increase in the likelihood that a patient would need to get oxygen or to go on a ventilator, according to the new study. | A study by European scientists is the first to document a strong statistical link between genetic variations and Covid-19, the illness caused by the coronavirus. Having Type A blood was linked to a 50 percent increase in the likelihood that a patient would need to get oxygen or to go on a ventilator, according to the new study. |
The unemployment rate fell to 13.3 percent in May, the Labor Department said on June 5, an unexpected improvement in the nation’s job market as hiring rebounded faster than economists expected. Economists had forecast the unemployment rate to increase to as much as 20 percent, after it hit 14.7 percent in April, which was the highest since the government began keeping official statistics after World War II. But the unemployment rate dipped instead, with employers adding 2.5 million jobs, after more than 20 million jobs were lost in April. | The unemployment rate fell to 13.3 percent in May, the Labor Department said on June 5, an unexpected improvement in the nation’s job market as hiring rebounded faster than economists expected. Economists had forecast the unemployment rate to increase to as much as 20 percent, after it hit 14.7 percent in April, which was the highest since the government began keeping official statistics after World War II. But the unemployment rate dipped instead, with employers adding 2.5 million jobs, after more than 20 million jobs were lost in April. |
States are reopening bit by bit. This means that more public spaces are available for use and more and more businesses are being allowed to open again. The federal government is largely leaving the decision up to states, and some state leaders are leaving the decision up to local authorities. Even if you aren’t being told to stay at home, it’s still a good idea to limit trips outside and your interaction with other people. | States are reopening bit by bit. This means that more public spaces are available for use and more and more businesses are being allowed to open again. The federal government is largely leaving the decision up to states, and some state leaders are leaving the decision up to local authorities. Even if you aren’t being told to stay at home, it’s still a good idea to limit trips outside and your interaction with other people. |
Common symptoms include fever, a dry cough, fatigue and difficulty breathing or shortness of breath. Some of these symptoms overlap with those of the flu, making detection difficult, but runny noses and stuffy sinuses are less common. The C.D.C. has also added chills, muscle pain, sore throat, headache and a new loss of the sense of taste or smell as symptoms to look out for. Most people fall ill five to seven days after exposure, but symptoms may appear in as few as two days or as many as 14 days. | Common symptoms include fever, a dry cough, fatigue and difficulty breathing or shortness of breath. Some of these symptoms overlap with those of the flu, making detection difficult, but runny noses and stuffy sinuses are less common. The C.D.C. has also added chills, muscle pain, sore throat, headache and a new loss of the sense of taste or smell as symptoms to look out for. Most people fall ill five to seven days after exposure, but symptoms may appear in as few as two days or as many as 14 days. |
If air travel is unavoidable, there are some steps you can take to protect yourself. Most important: Wash your hands often, and stop touching your face. If possible, choose a window seat. A study from Emory University found that during flu season, the safest place to sit on a plane is by a window, as people sitting in window seats had less contact with potentially sick people. Disinfect hard surfaces. When you get to your seat and your hands are clean, use disinfecting wipes to clean the hard surfaces at your seat like the head and arm rest, the seatbelt buckle, the remote, screen, seat back pocket and the tray table. If the seat is hard and nonporous or leather or pleather, you can wipe that down, too. (Using wipes on upholstered seats could lead to a wet seat and spreading of germs rather than killing them.) | If air travel is unavoidable, there are some steps you can take to protect yourself. Most important: Wash your hands often, and stop touching your face. If possible, choose a window seat. A study from Emory University found that during flu season, the safest place to sit on a plane is by a window, as people sitting in window seats had less contact with potentially sick people. Disinfect hard surfaces. When you get to your seat and your hands are clean, use disinfecting wipes to clean the hard surfaces at your seat like the head and arm rest, the seatbelt buckle, the remote, screen, seat back pocket and the tray table. If the seat is hard and nonporous or leather or pleather, you can wipe that down, too. (Using wipes on upholstered seats could lead to a wet seat and spreading of germs rather than killing them.) |
If you’ve been exposed to the coronavirus or think you have, and have a fever or symptoms like a cough or difficulty breathing, call a doctor. They should give you advice on whether you should be tested, how to get tested, and how to seek medical treatment without potentially infecting or exposing others. | If you’ve been exposed to the coronavirus or think you have, and have a fever or symptoms like a cough or difficulty breathing, call a doctor. They should give you advice on whether you should be tested, how to get tested, and how to seek medical treatment without potentially infecting or exposing others. |
If you’re sick and you think you’ve been exposed to the new coronavirus, the C.D.C. recommends that you call your healthcare provider and explain your symptoms and fears. They will decide if you need to be tested. Keep in mind that there’s a chance — because of a lack of testing kits or because you’re asymptomatic, for instance — you won’t be able to get tested. | If you’re sick and you think you’ve been exposed to the new coronavirus, the C.D.C. recommends that you call your healthcare provider and explain your symptoms and fears. They will decide if you need to be tested. Keep in mind that there’s a chance — because of a lack of testing kits or because you’re asymptomatic, for instance — you won’t be able to get tested. |
But the complaint says Dr. Bright found an ally in Peter Navarro, Mr. Trump’s trade adviser, who “shared Dr. Bright’s sense of urgency, recognized his expertise and was prepared to help.” In early February, an official from a company that makes masks connected Dr. Bright with Mr. Navarro, and the two met at the White House on Feb. 8, a Saturday, more than a month before Mr. Trump declared a national emergency. | |
In that meeting, the complaint said, Dr. Bright urged Mr. Navarro to have the government stop exporting high-quality N95 masks, stock up on remdesivir, an antiviral drug approved last week by the F.D.A. to treat Covid-19, and develop a “Manhattan Project” for a vaccine — an idea Mr. Trump recently adopted. | In that meeting, the complaint said, Dr. Bright urged Mr. Navarro to have the government stop exporting high-quality N95 masks, stock up on remdesivir, an antiviral drug approved last week by the F.D.A. to treat Covid-19, and develop a “Manhattan Project” for a vaccine — an idea Mr. Trump recently adopted. |
Mr. Navarro invited Dr. Bright back the following day to help him draft recommendations for the president’s coronavirus task force — a move that angered top department officials, the complaint said. | Mr. Navarro invited Dr. Bright back the following day to help him draft recommendations for the president’s coronavirus task force — a move that angered top department officials, the complaint said. |
Dr. Bright is asking the Office of Special Counsel to take steps to force the department to reinstate him as head of BARDA. In a brief statement during a conference call convened by his lawyers, he said the past few years “have been beyond challenging.” | Dr. Bright is asking the Office of Special Counsel to take steps to force the department to reinstate him as head of BARDA. In a brief statement during a conference call convened by his lawyers, he said the past few years “have been beyond challenging.” |
“Time after time, I was pressured to ignore or dismiss expert scientific recommendations and instead to award lucrative contracts based on political connections,” Dr. Bright said. | “Time after time, I was pressured to ignore or dismiss expert scientific recommendations and instead to award lucrative contracts based on political connections,” Dr. Bright said. |
Dr. Bright was named to lead BARDA a day after Mr. Trump’s election in November 2016, inheriting an agency full of fights with companies over contracting approvals. He proved a polarizing figure. | Dr. Bright was named to lead BARDA a day after Mr. Trump’s election in November 2016, inheriting an agency full of fights with companies over contracting approvals. He proved a polarizing figure. |
Bruce Gellin, the former director of the department’s National Vaccine Program Office, described Dr. Bright as a “visionary thinker” who pushed BARDA to take risks and innovate. But some lobbyists and pharmaceutical executives say that under Dr. Bright, the disputes over contracting worsened, a situation that led to a review by an outside consulting firm to evaluate the situation. | Bruce Gellin, the former director of the department’s National Vaccine Program Office, described Dr. Bright as a “visionary thinker” who pushed BARDA to take risks and innovate. But some lobbyists and pharmaceutical executives say that under Dr. Bright, the disputes over contracting worsened, a situation that led to a review by an outside consulting firm to evaluate the situation. |
The consultant, Mitre Corporation, issued two reports; neither is publicly available. The first concluded that some companies were badly treated by BARDA and included criticism that it lacked technical prowess and professionalism, according to two people who were told about its contents. It was later rewritten to include more flattering information about BARDA that was left out of the first report. | The consultant, Mitre Corporation, issued two reports; neither is publicly available. The first concluded that some companies were badly treated by BARDA and included criticism that it lacked technical prowess and professionalism, according to two people who were told about its contents. It was later rewritten to include more flattering information about BARDA that was left out of the first report. |
But the final straw for Dr. Bright came when Mr. Trump started pushing hydroxychloroquine as a possible “game changer” in the treatment of the virus. Dr. Bright pushed to limit access to the drug to hospitalized patients, but grew troubled when administration officials, including Dr. Kadlec, continued to press for its widespread usage, the complaint said. | But the final straw for Dr. Bright came when Mr. Trump started pushing hydroxychloroquine as a possible “game changer” in the treatment of the virus. Dr. Bright pushed to limit access to the drug to hospitalized patients, but grew troubled when administration officials, including Dr. Kadlec, continued to press for its widespread usage, the complaint said. |
When a Reuters reporter contacted him, he shared emails with the news outlet. Its story was published on April 16, and Dr. Bright was removed less than a week later. | When a Reuters reporter contacted him, he shared emails with the news outlet. Its story was published on April 16, and Dr. Bright was removed less than a week later. |
Michael D. Shear contributed reporting. | Michael D. Shear contributed reporting. |